German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.
The CSIRO has successfully appealed a decision that blocked the government agency’s application to patent a method of producing high-fibre wheat.
The High Court has unanimously granted home retailer Bed Bath N’ Table’s appeal of a ruling that retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
After years of pre-trial stoushes, a trademark dispute over Russian vodka has worn a Federal Court judge’s patience thin, with the judge remarking that the court was entitled to expect better from the litigants.
Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno’s generic version of schizophrenia drug Invega Sustenna.
A wellness retreat has launched an intellectual property suit against luxury Queensland resort Elysium Noosa, claiming that a recent rebrand amounts to passing off.
The High Court will not hear sports merchandise company Fanatics’ trade mark fight with AFL apparel maker FanFirm, which Fanatics argued would provide guidance on the defence of honest concurrent use.
Car dealership software firm Pentana has accused competitor Titan of a “calculated, sustained and brazen” invasion of its rights, and argues cross-claims of misuse of market power are a distraction.
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.
In a copyright and competition fight with car dealer software company Pentana that heads to trial on Monday, Titan DMS says its rival is trying to bar it from helping customers overcome a practice of holding their data “hostage”.